BRAINS FOR BRAIN Onlus Foundation (B4B)

All posts in Meeting

Overview and Highlights of the 8th B4B WORKSHOP & INNERMED 1st OPEN CONFERENCE – Frankfurt March 7th – 9th, 2014

Frankfurt_2014

 

The Brains for Brain Foundation (B4B) is an International Task Force formed by outstanding scientists and clinicians leaders in the neurological field, grouped together with patient advocacy groups and biotech companies to create coordinated and organized research projects aimed at the comprehension and cure of rare genetic diseases that affect and seriously damage the brain,  particularly in children.

 

The “Inherited NeuroMetabolic Diseases Information Network” (InNerMeD-I-Network, European Commission, Executive Agency for Health and Consumers, Agreement number: 2012 12 12, Second Health Programme 2008-2013) is the first European  Information Network on Inherited NeuroMetabolic Diseases.

 

Inherited NeuroMetabolic Diseases (iNMDs) represent an important group of Rare Diseases constituted by genetic metabolic disorders showing clinical neurologic/cognitive symptoms at any time of the disease progression. They are among the most serious genetic diseases at early onset that, involving the central nervous system (CNS), progressively lead to the appearance of irreversible disabilities. Many of the available treatments can result efficacious only if they are administered before neurodegeneration becomes irreversible.

Unfortunately, because of the low-prevalence of these disorders, there is often a striking lack of information, research, treatment and expert availability. There is also often a significant delay before a definitive diagnosis is achieved. Increasing awareness is therefore the first crucial step in fighting these conditions.

The Project InNerMeD-I-Network started on April 2013, with the aim to create a multimedial network of information targeted on research, diagnosis and treatment of inherited iNMDs and it is based on the collection and exchange of validated information among scientific communities, health professionals, patients, patient associations public health authorities, pharmaceutical companies and other interested parties.

B4B is the organization leading the InNerMeD-I-Network and thanks to its meaningful expertise in the management of projects and its long-standing experience and solid clinical competence in the field of child neurological disorders assures the partners coherence and ability to share decisions and put together relevant knowledge and research competences. In particular, because of its solid experience in developing and fostering networking and collaboration of synergy among research centres and experts and its capacity in strengthening the tie between basic and clinical research in the neurological field, B4B  is responsible for the exploitation and dissemination of new scientific knowledge.

To this aim, B4B has recently organized the 8thB4B Workshop and InNerMeD-I-Network 1st Open Conference, jointly held in Frankfurt, at the Mercure Hotel, on March 7th – 9th, 2014.

foto (13)

This edition brought together more than 60 participants.

The increasing number of participants that every year attend the annual B4B Symposium is a sign of the increasing awareness of the importance of interdisciplinary dialogue among experts working in the field of iNMDs. Moreover the active participation of new and old attendees, seriously committed to combine their forces and their scientific experiences, is a prove of evidence of the successful networking activity performed by the Brains for Brain International Foundation on behalf of all InNerMed-I Project Partners.

 

foto (23)

The meeting was aimed to enable the exchange of information among clinicians, basic scientists and experts specialized in inherited neurometabolic diseases (iNMDs), pharmaceutical companies and family associations.Invited speakers, all prestigious Professors from European and non European countries, discussed  the following topics:

  • Basic aspect of iNMDs and in particular Lysosomal Storage Diseases (LSDs)
  • Pathophysiology of these diseases
  • Strategy to overcome the Blood Brain Barrier and therapeutic options
  • B4B and InNerMeD-I-Network European actions
  • Biotech collaborations

Assessment of the results, contribution to the future direction of the field, outcomes

A broad discussion on brain function in normal and pathological conditions was performed with particular attention to the recent advances in diagnostic, treatment options, and technological strategies for a successful management of different neurological affections, in particular LSDs. It was also emphasized the important role of an early intervention in preventing the morbidity and mortality associated with each of the disorders. The programme culminated with the public presentation of the InNerMed project, its objectives and development process, its strategic relevance, its methods and means with particular attention to the dedicated website platform.

foto (17)

The informal feedback given by the participants was very positive throughout. Many stressed that they had learnt a lot from colleagues working in different fields of science. The meeting was in fact very useful for establishing new interactions between the participants and strengthening existing ones. The Workshop objectives of sharing knowledge and experience and initiating joint work were achieved. Participants were able to learn more about the pathophysiology of iNMDs and state of the art of development of new therapeuthical approaches for crossing the blood brain barrier. It represented a great opportunity for facilitating the sharing of information and experimental unpublished data.

 

foto (16)

The workshop clearly confirmed the fact that LSDs provide excellent models to develop the further understanding of neuro-pathophysiology and deciphering mechanisms responsible of brain alterations in neurodegeneration and consequently develop new approaches for:

  • an early identification and diagnosis of neurodegenerative disorders caused by storage of macromolecules, and their pathophysiology;
  • the study of the physiology of the blood brain barrier by creation of in vitro models and analysis of  models;
  • the development of new strategies to cross the blood brain barrier as a major goal to achieve brain therapy and to modify in a positive manner the natural history of these lethal progressive diseases.

All the derived results will be important for the research and treatment of other neurodegenerative disorders in the adulthood (i.e. Alzheimer and Parkinson disease) where effective therapy, often of “difficult” molecules such as biopharmaceuticals, may also be required.

The most effective way of achieving this aim is through the establishment of a combined multidisciplinary approach involving clinicians, basic scientists, biotech companies and family associations.

foto (15)

The meeting reinforced several key themes and saw also a number of emerging issues including the necessity to promote the education of high skilled young professionals to ensure perpetuation of knowledge in next generation of medical and basic scientists. The loss of expertise in rare neurometabolic disorders due to the ageing and retirement of a generation of scientists represents, in fact, a crucial problem in the field of iNMDs since it aggravates the “brain drain” and the scarcity of expertise in rare disease.

It was interesting to note the extent of common concerns among participants across the range of different kinds of projects and organizations.

 

 

 

Frankfurt 2014 – March, 7th-9th 2014

frankfurt_2014

Frankfurt_20148th BRAINS FOR BRAIN PLENARY WORKSHOP
and
INNERMED INFORMATION NETWORK 1st OPEN CONFERENCE
Frankfurt, Germany,
Mercure Hotel Frankfurt Airport
March 7th – 9th, 2014

Brains for Brain Foundation (B4B), the organization leading the “Inherited NeuroMetabolic Disease Information Network” (InNerMeD-I Network) project, is pleased to announce that “THE EIGHTH B4B WORKSHOP AND INNERMED INFORMATION NETWORK 1ST OPEN CONFERENCE” will be jointly held in Frankfurt on March 7th – 9th, 2014.

The meeting aims to enable information exchange among clinicians, basic scientists and experts specialised in inherited neurometabolic diseases (iNMDs), pharmaceutical companies and family associations.

Workshop

 

Invited speakers, all prestigious Professors from European and non European countries will discuss the following topics:
Basic aspect of iNMDs and in particular Lysosomal Storage Diseases (LSDs)
Pathophysiology of these diseases
Strategy to overcome the Blood Brain Barrier and therapeutic options
B4B and InNerMeD-I Network European actions
Biotech collaborations

A broad discussion on brain function in normal and pathological conditions will be performed with particular attention to the recent advances in diagnostic, treatment options, and technological strategies for a successful management of different neurological affections, in particular LSDs. It will also be emphasised the important role of an early intervention in preventing the morbidity and mortality associated with each of the disorders. The programme will culminate with the public presentation of the InNerMeD project, its objectives and development process, its strategic relevance, its methods and means with particular attention to the dedicated website platform.
The meeting represents an excellent occasion to foster fruitful scientific interactions and discussions. Infact it provides a great opportunity for exchanging information and for discussing the last most relevant research findings on iNMDs.
The increasing number of participants that every year attend the annual B4B Symposium are a sign of the increasing awareness of the importance of interdisciplinary dialogue among experts working in the field of iNMDs. Moreover the active participation of new and old attendees, seriously committed to combine their forces and their scientific experiences, is a prove of evidence of the successful networking activity performed by the Brains for Brain International Foundation on behalf of all InNerMeD-I Project Partners.

B4B EP ROUNDTABLE

ep-roundtable

banner_baw_int

“Paving the Way for a Competitive and Dynamic EU Knowledge Economy: the Way Forward in Rare Diseases”. Rare Neurometabolic Pediatric Diseases: a joint effort is needed for a competitive and dynamic EU knowledge economy.

Download PDF

Brussels, 26 November 2013 – The Roundtable, spearheaded by the Brains for Brain international research foundation and hosted by MEP Amalia Sartori, Chairwoman of the Parliament’s Industry, Research and Energy (ITRE) Committee and MEP Maria Graça da Carvalho (ITRE Committee), was held in the European Parliament in Brussels (Belgium). The meeting rallied numerous relevant stakeholders to discuss initiatives aiming to create a model of intersectoral cooperation that could facilitate the set-up of a European PhD Programme in the area of rare neurometabolic paediatric diseases (RPNMDs). In line with the core principles established by “Towards a Maastricht for Research” (The Maastricht for Research Manifesto, published by MEP Amalia Sartori and MEP Luigi Berlinguer in June 2013), the Brains for Brain Foundation has in fact created a network of Universities and Scientific Societies to start a doctorate programme aimed at furthering the knowledge on neurometabolic diseases amongst young physicians and scientists in order to establish an European Network of specialized experts and maintain excellence in Europe. Such initiative intends to enhance an advance awareness and knowledge about RPNMDs via cross-border collaboration and to enable better diagnosis and management of patients affected by these diseases.
All participants were highly motivated and overall there was a strong sense of collaboration and of excitement. The outcome of the workshop was very encouraging and positive. It was generally agreed that overcoming barriers in health research and reversing the brain drain should be made political priorities at European level. This will require action from policy makers, hospital administrators, healthcare providers, patient groups and citizens across Europe. During the meeting researchers, clinicians, patient advocacy groups, and many other interested stakeholders from 20 European organisations active in the field of health have signed the B4B Manifesto to maximise investments in health research and advance care for children with rare neurometabolic diseases. B4B Roundtable represents a major step toward the establishment of a successful EU cross border collaboration and cooperation to raise awareness about RPNMDs and keep them on the health-care agenda. Although individually rare by definition, RPNMDs collectively affect millions of people worldwide. Joint forces to tackling rare diseases are essential to ensure that children affected by RPNMDs are given the priority they deserve and that they needs are met.

© European Union 2013 – EP, http://audiovisual.europarl.europa.eu